This article describes the efficacy of using orforglipron as a maintenance therapy after treatment with semaglutide or tirzepatide at maximum tolerated dose
For example, older adults, people who lose weight quickly, and those taking water pills (diuretics) may have a higher chance of low blood pressure
For detailed appeal strategies, see our complete Foundayo appeals guide
However, evidence is still limited and more human research is needed
Theyre known for: No insurance requirements No waitlist Fast turnaround (approval + shipping in 3 days or less) A bold money-back guarantee if you dont hit your weight loss goals in 6 to 12 months They prescribe compounded semaglutidean alternative to the brand-name GLP-1 medications like Ozempic and Wegovyand ship directly to you
With the emergence of the SURPASS-CVOT trial, tirzepatide (a dual GIP/GLP-1 receptor agonist) has entered the therapeutic landscape